ANI製藥 ANIP 深 滬
已收盤 10-17 16:00:00 美东时间
94.79
+2.840
+3.09%
華盛通- 最 高95.94
- 今 開90.70
- 成交量 31.54万股
- 最 低 90.70
- 昨 收 91.95
- 總市值 21.13亿
- 52周最高 99.50
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 52.50
- 委 比 56.25%
- 總股本 2229.17万
- 歷史最高 99.50
- 量 比 1.60
- 振 幅 5.70%
- 歷史最低 0.80
- 每 手 1
- 風險率 13.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting
ANI Pharmaceuticals announced that results from the NEW DAY clinical trial of ILUVIEN for diabetic macular edema (DME) will be presented in a late-breaking oral presentation at the American Academy of Ophthalmology (AAO) 2025 Meeting. The presentation, titled "A Randomized, Active-Controlled Trial of Fluocinolone Acetonide 0.19mg Intravitreal Implant for Diabetic Macular Edema: The NEW DAY Study," will be delivered by Victor H. Gonzalez, MD, duri...
10-16 10:50
美股大行评级 | 潜在涨幅334.0%！HC Wainwright & Co.上调Inventiva目标价至24美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Inventiva"买入"评级，目标价从20美元升至24美元；摩根大通：维持BioMarin Pharmaceutical"超配"评级，目标价从116美元升至119美元
10-10 11:36
Truist Securities Maintains Hold on ANI Pharmaceuticals, Raises Price Target to $90
Truist Securities analyst Gregory Fraser maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Hold and raises the price target from $77 to $90.
10-09 22:41
Adani Ports Receives SEBI Compliance Certificate for Q3 2025
An announcement from Adani Ports & Special Economic Zone Ltd ( ($IN:ADANIPO...
10-07 02:35
ANI Pharmaceuticals Completes Mandatory Conversion of Preferred Shares
The latest announcement is out from ANI Pharmaceuticals ( ($ANIP) ). On Novembe...
09-27 05:30
美股大行评级 | 217美元！花旗上调阿里巴巴目标价；多家机构集体上调麦克森、美光科技等目标价
今日重点评级关注：Ascendiant Capital：维持Maison Solutions"买入"评级，目标价从4美元升至4.25美元；瑞穗：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至56美元
09-25 09:52
6 Analysts Have This To Say About ANI Pharmaceuticals
Throughout the last three months, 6 analysts have evaluated ANI Pharmaceuticals...
09-24 21:01
美股大行评级 | Tigress Financial：维持苹果"强烈买入"评级，目标价升至305美元；杰富瑞维持百度"买入"评级，目标价升至157美元
今日重点评级关注：HC Wainwright & Co.：维持Astria Therapeutics"买入"评级，目标价从16美元升至20美元；HC Wainwright & Co.：维持Avalo Therapeutics"买入"评级，目标价从15美元升至25美元
09-18 10:13
HC Wainwright & Co. Maintains Buy on ANI Pharmaceuticals, Raises Price Target to $121
HC Wainwright & Co. analyst Brandon Folkes maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price target from $93 to $121.
09-17 22:36
4 Analysts Have This To Say About ANI Pharmaceuticals
In the last three months, 4 analysts have published ratings on ANI Pharmaceutic...
09-09 04:00
